What is the appropriate management of cholesteatoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cholesteatoma Management

Surgical excision is the definitive treatment for cholesteatoma, as there are no effective nonsurgical options available. 1 The primary goal is to achieve a dry, safe, and functional ear by completely eradicating the disease while preserving or restoring hearing function. 2

Preoperative Imaging

Obtain CT temporal bone without IV contrast for all patients with suspected cholesteatoma to assess disease extent, ossicular chain integrity, and identify anatomic complications such as tegmen erosion, facial canal dehiscence, or lateral semicircular canal erosion. 3 This imaging provides excellent bone detail and helps guide surgical planning. 3

Add MRI head and internal auditory canal (IAC) without and with IV contrast, specifically including nonechoplanar diffusion-weighted imaging (DWI) in the coronal plane, to differentiate cholesteatoma from granulation tissue, scar, or other soft tissue pathology. 3 This combination achieves high sensitivity and specificity for cholesteatoma detection and is particularly valuable for presurgical planning. 3

Surgical Approach Selection

The choice between canal wall-up (CWU) and canal wall-down (CWD) mastoidectomy depends on disease extent and severity:

Canal Wall-Up Tympanomastoidectomy (TM-CWU)

  • Use for moderate disease where complete visualization and removal is achievable while preserving the posterior canal wall. 4
  • Advantages: Better cosmetic outcome, no need for meatoplasty, maintains normal ear canal anatomy 5
  • Critical caveat: This approach has significantly higher revision rates compared to both simple tympanoplasty and CWD approaches (mean difference +0.34 procedures vs CWD, P<0.0001). 4 This reflects the challenge of complete disease eradication while maintaining canal wall integrity.

Canal Wall-Down Tympanomastoidectomy (TM-CWD)

  • Use for extensive or aggressive cholesteatoma where complete disease removal requires posterior canal wall removal. 4, 5
  • This approach achieves lower recidivism and recurrence rates, resulting in fewer total surgical procedures over time (0.34 fewer procedures than CWU, P<0.0001). 4
  • Disadvantages: Requires lifelong cavity care, potential for chronic drainage, cosmetic concerns 5

Simple Tympanoplasty (TM)

  • Reserve for small, limited cholesteatomas confined to the tympanic membrane or attic without mastoid involvement. 4
  • This approach has the lowest rate of hearing aid requirement (1.2% vs 1.9% CWU vs 2.7% CWD, P<0.03) 4, likely reflecting selection for less severe disease.

Atticotomy/Limited Mastoidectomy

  • Consider this "third way" approach through an endaural incision for appropriately selected cases, creating small, dry, self-cleaning cavities without pinna protrusion or need for meatoplasty. 5
  • The extent (atticotomy, atticoantrostomy, or limited mastoidectomy) is tailored to cholesteatoma size and location. 5

Surgical Technique Considerations

Utilize endoscopic ear surgery techniques to augment visualization and improve disease eradication, particularly in hidden recesses. 2 Endoscopic approaches enhance the surgeon's ability to identify and remove cholesteatoma in areas difficult to access with microscopic visualization alone.

Consider mastoid obliteration techniques in conjunction with CWU approaches to reduce recidivistic disease rates, though this requires further standardization and research. 2

Postoperative Surveillance

Obtain CT temporal bone without IV contrast for surveillance imaging to detect recurrent cholesteatoma by identifying abnormal lobulated material and subtle osseous erosions. 3 The combination of preoperative HRCT and audiological assessments provides accurate estimation of ossicular erosion degree. 3

Use MRI head and IAC without and with IV contrast including DWI and delayed postcontrast T1-weighted imaging for postoperative assessment, as this enables differentiation between keratinous debris and non-cholesteatoma findings such as granulation tissue or scar. 3

Hearing Rehabilitation

Following cholesteatoma surgery, hearing rehabilitation options include:

  • Air-conduction hearing aids for patients with intact external auditory canal and adequate residual hearing 6
  • Bone-conduction devices (implantable or non-implantable) for patients with conductive hearing loss or CWD cavities 6
  • Assistive listening devices including FM systems, hearing loops, and Bluetooth technology for enhanced speech understanding in noisy environments 6

The choice between CWU and CWD approaches influences hearing outcomes, with CWU generally preserving better hearing but at the cost of higher revision rates. 6, 4

Key Clinical Pitfalls

  • Never attempt nonsurgical management of cholesteatoma - there are no effective medical treatments, and delay allows progressive bone destruction and potential intracranial complications. 1
  • Do not rely on CT alone for preoperative planning - MRI with DWI is essential to differentiate cholesteatoma from inflammatory tissue and scar. 3
  • Avoid underestimating pediatric cholesteatoma - children face higher recurrence rates due to anatomical, pathophysiological, and Eustachian tube dysfunction factors. 5
  • Recognize that CWU approaches require more vigilant long-term surveillance due to significantly higher revision rates. 4

References

Research

Principles of Cholesteatoma Management.

Otolaryngologic clinics of North America, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Outcomes in Pediatric Cholesteatoma.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Research

Management of Cholesteatoma: Hearing Rehabilitation.

Otolaryngologic clinics of North America, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.